Skip to content

Intelligent Regulation Method and Experimental Research of Electrical Stimulator Based on Multimodal Perception

Intelligent Regulation Method and Experimental Research of Electrical Stimulator Based on Multimodal Perception

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119905
Enrollment
Unknown
Registered
2026-03-05
Start date
2025-10-25
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Limb Dysfunction Following Stroke

Interventions

Control group:The control group was treated with the clinical conventional fixed-parameter open-loop neuromuscular electrical stimulator (model: German Pierenkemper NT2000). This device does not have
Model Group:The experimental group adopted the closed-loop intelligent electrical stimulation system developed by our research team. This system integrates high-precision surface electromyography sens

Sponsors

Gongli Hospital, Pudong New District, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 45–75 years; 2. Clinically and radiologically diagnosed (CT/MRI) with a first-ever stroke affecting one cerebral hemisphere, and the disease has entered the chronic phase (>3 months); 3. Mild to moderate dysfunction in the wrist dorsiflexor muscles of the affected upper limb, with a manual muscle testing score of 2–4; 4. Clear consciousness, no severe cognitive impairment (Mini-Mental State Examination score >=24), able to understand and follow instructions from therapists; 5. Meets the basic criteria for mandatory physical therapy (wrist dorsiflexion of the affected side >=10°).

Exclusion criteria

Exclusion criteria: 1. Presence of severe cardiac, pulmonary, liver, or renal dysfunction, or malignant tumors, blood system diseases, and other systemic conditions that may affect the safety of treatment; 2. Severe spasticity in the affected limb (modified Ashworth scale rating > grade 3), joint contracture, or pain (visual analogue scale score > 4 points); 3. Skin damage, infection, or severe sensory loss in the treatment area; 4. Implantation of electronic medical devices such as a pacemaker; 5. Known allergy to electrical stimulation or a history of severe adverse reactions; 6. Severe aphasia, apraxia, or mental illness that prevents effective communication and cooperation.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Upper Limb Motor Function Assessment Scale;

Secondary

MeasureTime frame
sEMG fatigue index;sEMG fundraising indicators;NIRS metabolic indicators;Therapeutic tolerance;

Countries

China

Contacts

Public ContactShao Jingwen

Gongli Hospital, Pudong New District, Shanghai

echo19880804@163.com+86 137 9549 5756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026